who we are

---

We honed our processes at The Innovation Factory (TIF) providing diligence support for Accuitive Medical Ventures. Through the strategic review of assets, assessment of intellectual property, evaluation of market dynamics, determination of clinical adoption hurdles, development of regulatory and clinical trial strategies, validation of reimbursement strategies, identification of development risks and the operating capability of management teams, we sharpened our focus on value creation.

In addition to investment diligence, fourteen companies were launched and operated by The Innovation Factory team; a team that formulated operating plans, raised venture funds, engineered devices, developed and defended intellectual property, executed animal studies, conducted human feasibility  studies, negotiated with regulatory bodies, executed pivotal clinical trials, garnered regulatory approval (both US and OUS), commercialized products and sold companies.

Attentive Partners has built on these experiences and adheres to a de novo process for each opportunity that intensely focuses on the following:

• MARKET NEED: Therapeutic areas with unmet clinical or commercial need
• CLINICAL UTILITY: Differentiation in product profile to enhance clinical utility
• NOVELTY: Unique mechanism of action 
• STRATEGIC RELEVANCE: Ability to create a strategic asset for potential acquirers
• NOT INCREMENTAL: Best-in-class efficacy with a focus on reducing cost and improving process or delivery
• PROFITABLE: Products that demonstrate a road map to significant margins, leading to accretive income for strategics
• PROTECTABLE: Good foundational IP at a minimum, with the ability to build a strong portfolio
• CLEAR REGULATORY PATH: Manageable regulatory requirements and a clear FDA/CE Mark strategy

Our model looks to establish a unique competitive advantage for company creation, financing strategies or other investment thesis’. Through serial company creation experience our skills remain on the leading edge of managing technical development.

Leveraging our experience, allows the Attentive team to quickly diagnose and solve problems. The experience of having conducted multiple clinical trials on 5 continents ranging from small pilot studies to 400 patient pivotal trials, allows Attentive Partners to successfully determine the right country, at the right time for the right costs for pre-clinical and human trials.

Our style of hands on management and commitment ensures a focus on business, clinical and engineering milestones with significant capital efficiency.